Last reviewed · How we verify
NCT03806829
The Acute Effects of Commercially Available Drinks on the Endothelial Function of Humans Following a High-fat Meal
NA trial testing Water in Endothelial Dysfunction in 7 participants. Completed in 31 July 2018.
31 July 2018
Quick facts
| Lead sponsor | University of the Highlands and Islands |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 7 |
| Start date | 6 June 2018 |
| Primary completion | 31 July 2018 |
| Estimated completion | 31 July 2018 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Water (WATER) — full drug profile →
- Red Wine
- Green Tea — full drug profile →
- Orange Juice — full drug profile →
Conditions studied
- Endothelial Dysfunction — all drugs for Endothelial Dysfunction →
Sponsor
University of the Highlands and Islands
Who can join
Adults 50 to 65, any sex, with Endothelial Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
High fat diets are associated with impaired endothelial function and increased cardiovascular disease risk amongst our population. These negative effects are likely caused by triglyceride induced suppression of nitric oxide, which is produced from the endothelium, and/or an increase in oxidative stress. Interestingly, previous studies have found that some beverages that are high in polyphenols and antioxidants may suppress the impairment in endothelial function observed following high fat meals/diets. Typically, these studies have investigated the ingestion of red wine, orange juice or green tea on outcome measures (typically flow mediated dilatation (FMD) of the brachial artery). Despite this previous research, no study has compared the effects of different beverages on endothelial outcomes following a high-fat meal within the same participants.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Co-ingestion of Antioxidant Drinks With an Unhealthy Challenge Meal Fails to Prevent Post-prandial Endothelial Dysfunction: An Open-Label, Crossover Study in Older Overweight Volunteers.
Muggeridge DJ, Goszcz K, Treweeke A, Adamson J, et al · · 2019 · cited 3× · PMID 31681007 · DOI 10.3389/fphys.2019.01293
Verify or expand the search:
- PubMed search for NCT03806829
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Water
Trials testing the same drug.
- NCT07367139 — Occupational Exposure to Whole Body Vibration Among U.S. Military Veterans: Acute and Chronic Contributions to Musculosk · NA · not yet recruiting
- NCT07507344 — Beverage Hydration Index of Different Solutions · NA · recruiting
- NCT07439198 — The Influence of Water Intake on Food Intake at Meals Varying in Moisture · NA · not yet recruiting
- NCT07459413 — Oral vs. Intravenous Hydration to Prevent Contrast-Associated Acute Kidney Injury in the ED · NA · recruiting
- NCT07361887 — Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles. · NA · recruiting
Other recruiting trials for Endothelial Dysfunction
Currently open trials in the same condition.
- NCT07487363 — TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD · Phase 1, PHASE2 · recruiting
- NCT07422974 — Perioperative Outcomes After Neoadjuvant Therapy in Colorectal Cancer · recruiting
- NCT06419959 — NightWare and Cardiovascular Health in Veterans With PTSD · NA · recruiting
- NCT07227727 — Endothelial Dysfunction After SCI · recruiting
- NCT07227740 — Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03806829 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of the Highlands and Islands
- Last refreshed: 16 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03806829.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing